China Will Seize Ranking As Globe's Top Innovative Center From U.S. By 2020: AstraZeneca Survey
This article was originally published in PharmAsia News
Executive Summary
BEIJING - A survey commissioned by British-headquartered AstraZeneca that polled public perceptions across three continents - Europe, North America and Asia -predicts that China will dethrone the United States to become the globe's most innovative center by 2020
You may also be interested in...
AstraZeneca R&D VP Steve Yang On Building R&D Success In Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)
The global pharma market in the next five years is expected to grow 3-6% compared to 6.2% in the past five years, while emerging markets will drive major growth and will hold 28% of global spending on medicines by 2015.
AstraZeneca R&D VP Steve Yang On Building R&D Success In Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)
The global pharma market in the next five years is expected to grow 3-6% compared to 6.2% in the past five years, while emerging markets will drive major growth and will hold 28% of global spending on medicines by 2015.